Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Qurasense · NCT07281599

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 25+ · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
450
US sites recruiting
3
Study start
December 1, 2025
Record last updated
July 24, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing.

The same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.

Being studied: Q-Pad hrHPV Test System

Conditions: HPV Infection; HPV 16 Infection; High Risk HPV; Cervical Cancer Screening; Cervical Cancer Cin Grade; Cervical Cancer (Early Detection); HPV; HPV (Human Papillomavirus)-Associated; HPV DNA; HPV Infections; Screening Test

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • You are 25 years old or older and have an intact cervix.
  • You were referred for a colposcopy after an abnormal Pap or HPV screen.
  • Your periods come regularly-about every 21-35 days.
  • You own a smartphone, have an email address, and can read the Qvin app instructions in English.
  • You are willing to sign the consent form (electronically).
  • You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.

Exclusion Criteria

  • You are pregnant or think you might be.
  • You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
  • You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
  • You have already joined this study or are in another cervical-screening / HPV study right now.

Recruiting US locations

  • Planned Parenthood of Southern New England

    New Haven, CT 06511

    Site contact: Danielle Salinas, MSCR · 203-903-0394 · danielle.salinas@ppsne.org

  • Planned Parenthood North Central States

    Minneapolis, MN 55408

    Site contact: Bridge McKye, MPH · 651-389-0675 · bmckye@ppncs.org

  • Planned Parenthood of Greater Ohio (PPGOH)

    Akron, OH 44302

    Site contact: Penny Paxton · 440-279-8109 · penny.paxton@ppoh.org

Study contacts (from the official record)

  • Brian Weinberg, MS · 833-367-7846 · care@qvin.com
All healthy volunteers studies in Connecticut →
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer (NCT07281599) | Bored Studies